PAPA Medical Inc.
PAPA
NASDAQ
Recommendation
Dividend Power Score
Prev Close
--
Volume
--
Avg Vol (90D)
--
Market Cap
--
Dividend & Yield
--
52-Week Range
-- - --
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -1.09% | -26.11% | 69.32% | 107.27% | 7.37% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -1.09% | -26.11% | 69.32% | 107.27% | 7.37% |
| Cost of Revenue | -2.22% | -22.04% | 67.01% | 114.96% | 8.17% |
| Gross Profit | 2.07% | -39.37% | 76.71% | 84.28% | 5.20% |
| SG&A Expenses | -29.18% | 31.83% | 63.93% | 79.91% | 46.85% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.54% | -10.13% | 67.16% | 108.01% | 17.44% |
| Operating Income | 289.50% | -473.30% | 107.24% | 94.73% | -166.38% |
| Income Before Tax | 223.27% | -405.40% | 97.98% | 102.36% | -181.32% |
| Income Tax Expenses | 141.79% | -500.35% | 632.57% | 22.69% | -223.98% |
| Earnings from Continuing Operations | 345.76% | -369.26% | 44.00% | 152.51% | -153.59% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 345.76% | -369.26% | 44.00% | 152.51% | -153.59% |
| EBIT | 289.50% | -473.30% | 107.24% | 94.73% | -166.38% |
| EBITDA | 22,005.00% | -374.91% | 144.29% | 103.88% | -99.29% |
| EPS Basic | 346.24% | -369.74% | 43.98% | 153.21% | -153.45% |
| Normalized Basic EPS | 252.54% | -393.13% | 110.14% | 105.66% | -166.29% |
| EPS Diluted | 346.24% | -369.74% | 43.98% | 153.21% | -153.45% |
| Normalized Diluted EPS | 252.54% | -393.13% | 110.14% | 105.66% | -166.29% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |